Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
In recent years, anti-angiogenic therapy has attracted much interest because it is a versatile approach to treating most types of tumors, and therefore would be expected to be applicable for various cancers. Severe adverse events in patients treated with currently available anti-angiogenic therapeut...
Saved in:
Main Authors: | Tomoya Hada (Author), Yu Sakurai (Author), Hideyoshi Harashima (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
by: Xiaolin Yu, et al.
Published: (2021) -
Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
by: Amir Nasrolahi Shirazi, et al.
Published: (2021) -
cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy
by: Shuang Yang, et al.
Published: (2021) -
An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo
by: Bohong Cen, et al.
Published: (2018) -
Feasibility of cRGD conjugation at 5'-antisense strand of siRNA by phosphodiester linkage extension
by: Xinyang Zhou, et al.
Published: (2021)